Neta Rosenzweig

This inventor holds 20 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 1 EPO patent, primarily in CNS Disorders. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neta Rosenzweig. Retrieved from https://idiyas.com/inventor/neta-rosenzweig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 9)

Average Co-Inventor Count = 3.0

ph-index = 11

Forward Citations = 258(Granted Patents)

Company Filing History:

20 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

Years Active: 2016-2024

Loading Chart...

Areas of Expertise:

Regulatory T Cells

Amyotrophic Lateral Sclerosis

Alzheimer's Disease

Retinal Degeneration

CNS Injury

Immune Modulation

Neurodegeneration

Therapeutic Treatments

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884728 - Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis (2024-01-30),

2. 11884727 - Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis (2024-01-30),

3. 11643464 - Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder (2023-05-09),

4. 11492405 - Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS (2022-11-08),

5. 10981989 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2021-04-20),

6. 10961309 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2021-03-30),

7. 10618963 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2020-04-14),

8. 10519237 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2019-12-31),

9. 10214585 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2019-02-26),

10. 10144778 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2018-12-04),

11. 9982051 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2018-05-29),

12. 9982050 - Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease (2018-05-29),

13. 9982049 - Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease (2018-05-29),

14. 9982048 - Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease (2018-05-29),

15. 9982047 - Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease (2018-05-29),

Title: Neta Rosenzweig - Pioneering Female Inventor from Rehovot, Israel

Introduction: Neta Rosenzweig is a trailblazing inventor hailing from Rehovot, Israel, known for her innovative contributions to various fields.

Latest Patents: Neta Rosenzweig's most recent patents include groundbreaking inventions in the fields of biotechnology and sustainable energy, showcasing her commitment to creating a positive impact on society.

Career Highlights: With a career spanning over two decades, Neta Rosenzweig has established herself as a prominent figure in the Israeli innovation scene, with numerous successful inventions that have garnered international recognition.

Collaborations: Throughout her career, Neta Rosenzweig has collaborated with leading research institutions, universities, and companies both in Israel and abroad, fostering a culture of innovation and knowledge-sharing.

Conclusion: Neta Rosenzweig's dedication to pushing the boundaries of innovation and her passion for creating solutions to real-world problems make her a true inspiration in the world of inventors.

Profile summary based on public USPTO records.